New study on Digital Breast Tomosynthesis performance for breast cancer screening

Dr. Christoph Lee is lead author of a recently published study indicating that since its implementation post-approval by the FDA in 2011, digital breast tomosynthesis (DBT) has improved breast cancer screening performance in community practice and identifies more invasive cancers compared to digital mammography. “Our study demonstrated that more radiologists in U.S. community practice are meeting recommended performance standards with digital breast tomosynthesis than they did with digital mammography,” states Lee.  “This is good news for women and breast cancer screening, as digital breast tomosynthesis has quickly become the most popular breast cancer screening modality in the U.S.” Dr. Janie Lee is co-author on the study.

Read the press release from RSNA here and for Health Imaging here